Cerapedics and Vizient signed a supplier agreement for the PearlMatrix P-15 peptide enhanced bone graft, according to an April 24 news release.
PearlMatrix is FDA approved for open or minimally invasive single-level anterior lumbar interbody fusion, posterior lumbar interbody fusion, oblique lumbar interbody fusion, lateral lumbar interbody fusion and transforaminal lumbar interbody fusion with PEEK titanoum cages.
The supplier agreement expands access to the bone graft for Vizient clients, which serves more than 65% of the nation’s acute care providers.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
